Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Subcontract opportunity from Department Of Defense was posted on July 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Supply of Atorvastatin Calcium 80 MG Tablets

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Request for Information (RFI) - Specialty – PPV 2028 Amendment 0002 to Extend Response Date from Nov. 16, 2026 to Nov. 30, 2026 at 11AM CT
Solicitation # 36E79727Q0001
The Department of Veterans Affairs, through the OALC Enterprise Procurement Office, has issued a Request for Information regarding the Pharmaceutical Prime Vendor (PPV) 2028 program. The agency is seeking market research to determine the feasibility of integrating Limited Distribution and Closed Distribution Products (CDP) into the PPV scope. These specialty medications are typically high-cost, low-volume items with restricted distribution channels that often require specific clinical justifications, manufacturer-mandated registrations, and specialized safety monitoring. The primary objective is to establish a seamless ordering platform where all Federal Supply Schedule (FSS) items, including those that bypass the physical possession of the prime vendor, are visible and orderable with accurate invoicing and delivery tracking for VA medical centers nationwide. The government is soliciting detailed feedback from industry partners on their ability to coordinate fulfillment with manufacturer-designated specialty distributors and their capacity to provide consistent reporting and reconciliation for these transactions. Potential respondents must provide their company name, point of contact information, UEI, CAGE code, and any applicable socioeconomic designations. Submissions are due by 11 AM Central on November 16, 2026, via email to Karen Ade. This notice is strictly for market research purposes and does not constitute a formal solicitation or a commitment by the government to award a contract.
Nac Prime Vendor (36W797)

POSTED

about 21 hours ago

DEADLINE

in 20 days

AI Contract Overview

Show more

The contract entails the annual supply of 6,633 bottles, each containing 90 tablets of Atorvastatin Calcium 80 MG, totaling nearly 600,000 tablets per year for a five-year period. This high-dose statin is intended for cholesterol management and will be procured under a subcontract arrangement by the Department of Defense through its Medical Supply Chain FSGB. The solicitation was posted on July 13, 2026, with a response deadline set for August 13, 2026, indicating an active procurement cycle targeting manufacturers or distributors capable of meeting the volume and quality requirements. The NAICS code 325412 confirms the involvement of pharmaceutical manufacturing, and while specific delivery locations are not detailed, performance is expected to align with federal supply chain protocols under DOD oversight. The absence of a set-aside designation suggests open competition among qualified vendors.

General Info

Annual supply of 6,633 bottles of Atorvastatin 80 MG tablets for five years under DOD subcontract.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2D2-25-R-0014.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

PHARM MANUF/DISTR DIV - FSA

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN FSGB
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of 6,633 bottles (90-count) annually for five years; high-dose statin for cholesterol management.

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN FSGB

Same awarding agency

NAICS: 325412
DIBBS
PHARM MANUF/DISTR DIV - FSA
Solicitation # SPE2D2-26-R-0009
Solicitation SPE2D2-26-R-0009 is a federal procurement issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain for the acquisition of Epinephrine Auto-Injectors in 2-count boxes. This is a lowest price technically acceptable (LPTA) acquisition, where the award will be granted to the responsible offeror who meets all technical requirements and past performance standards while providing the lowest evaluated aggregate price. The procurement is open to pharmaceutical prime vendors and requires that all products be FDA approved with a Therapeutic Equivalence Code of A, unless all drugs in the family group are B rated. Manufacturing must comply with current Good Manufacturing Practices (cGMP) and be cleared under a specific NDA, ANDA, or BLA. The contract mandates strict packaging and labeling standards, including the prohibition of glass bottles and the requirement for bar code labeling at the unit-of-use package level conforming to GS1-128 or HIBC standards. Bar codes must meet ANSI/ISO/IEC quality grade C or better and encode the National Drug Code, lot number, and expiration date. Following award, the contractor must be ready to fill orders within 45 calendar days, with prices becoming effective no more than 60 days after award. Proposals must be submitted electronically via DIBBS, and the final deadline for receipt of offers was extended to November 30, 2026, at 3:00 PM EST.
Pharmaceutical Preparation Manufacturing

POSTED

about 1 month ago

DEADLINE

in 20 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS